SYNTHESIS OF NOVEL HYDROLYTICALLY DEGRADABLE HYDROGELS FOR CONTROLLED DRUG-RELEASE

被引:68
作者
ULBRICH, K
SUBR, V
PODPEROVA, P
BURESOVA, M
机构
[1] Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 162 06 Prague 6
关键词
N-(2-HYDROXYPROPYL)METHACRYLAMIDE; DRUG TARGETING; CONTROLLED DRUG RELEASE; BIODEGRADABLE HYDROGEL; DOXORUBICIN; ADRIAMYCIN;
D O I
10.1016/0168-3659(95)00004-R
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper describes synthesis of hydrolytically degradable gels based on N-(2-hydroxypropyl)-methacrylamide copolymers with high potential for use in the synthesis of new drug release systems. The first part deals with a study of the dependence between conditions of crosslinking copolymerization, the course of copolymerization and final properties of hydrogels thus formed. The second part is devoted to the study of hydrolytic degradation of hydrogels and in vitro studies of doxorubicin and polymer-doxorubicin conjugate release from hydrogel matrix. We have shown that the hydrogels under study were stable under acidic conditions (in buffers at pH 5 and lower) and hydrolytically degradable at physiological pH (7.4). Both drug forms, free doxorubicin and its conjugate with water-soluble polymeric drug carrier, can be released from the hydrogel matrix at a rate depending on the rate of drug diffusion from the hydrogel, or the rate of hydrogel degradation, or at a rate controlled by a combination of both processes. In all cases the hydrogel matrix was degraded and a hydrophilic water-soluble polymeric product was formed. Biological evaluation of drug-hydrogel systems described in this paper is under way.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 18 条
[1]   HYDROGELS FOR SITE-SPECIFIC ORAL-DRUG DELIVERY - SYNTHESIS AND CHARACTERIZATION [J].
BRONDSTED, H ;
KOPECEK, J .
BIOMATERIALS, 1991, 12 (06) :584-592
[2]   HYDROGELS FOR SITE-SPECIFIC DRUG DELIVERY TO THE COLON - INVITRO AND INVIVO DEGRADATION [J].
BRONDSTED, H ;
KOPECEK, J .
PHARMACEUTICAL RESEARCH, 1992, 9 (12) :1540-1545
[3]   DRUG POLYMER CONJUGATES - POTENTIAL FOR IMPROVED CHEMOTHERAPY [J].
DUNCAN, R .
ANTI-CANCER DRUGS, 1992, 3 (03) :175-210
[4]  
Peppas N. A., 1987, HYDROGELS MED PHARM
[5]   BIOCOMPATIBILITY OF N-(2-HYDROXYPROPYL) METHACRYLAMIDE COPOLYMERS CONTAINING ADRIAMYCIN - IMMUNOGENICITY, AND EFFECT ON HEMATOPOIETIC STEM-CELLS IN BONE-MARROW INVIVO AND MOUSE SPLENOCYTES AND HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO [J].
RIHOVA, B ;
BILEJ, M ;
VETVICKA, V ;
ULBRICH, K ;
STROHALM, J ;
KOPECEK, J ;
DUNCAN, R .
BIOMATERIALS, 1989, 10 (05) :335-342
[6]  
RIHOVA B, 1992, J CONTROL RELEASE, V19, P25
[7]  
RIHOVA B, 1990, BIOACT COMPAT POLYM, V5, P249
[8]   SOLUBLE POLYMERS FOR LECTIN-MEDIATED DRUG TARGETING [J].
SEYMOUR, LW .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) :89-111
[9]   N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMERS TARGETED TO THE HEPATOCYTE GALACTOSE-RECEPTOR - PHARMACOKINETICS IN DBA2 MICE [J].
SEYMOUR, LW ;
ULBRICH, K ;
WEDGE, SR ;
HUME, IC ;
STROHALM, J ;
DUNCAN, R .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :859-866
[10]   POLY[N-(2-HYDROXYPROPYL)METHACRYLAMIDE] .4. HETEROGENEOUS POLYMERIZATION [J].
STROHALM, J ;
KOPECEK, J .
ANGEWANDTE MAKROMOLEKULARE CHEMIE, 1978, 70 (JUL) :109-118